CDT Equity (CDT) Shares Outstanding (Entity) (2021 - 2026)
CDT Equity (CDT) Shares Outstanding (Entity) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.95 Bn | 132.10 Bn | 2.84 Bn | 253.35 Mn |
| 2 | Regeneron Pharmaceuticals | 86.71 Bn | 78.72 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 65.71 Bn | 60.52 Bn | 1.37 Bn | 62.54 Mn |
| 4 | Moderna | 60.45 Bn | 55.31 Bn | 52.00 Mn | 399.00 Mn |
| 5 | BeOne Medicines | 42.24 Bn | 37.14 Bn | 1.53 Bn | 113.02 Mn |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn | 133.73 Mn |
| 7 | BioNTech SE | 28.64 Bn | 10.25 Bn | 668.28 Mn | 252.88 Mn |
| 8 | Insmed | 27.61 Bn | 26.45 Bn | 358.27 Mn | 218.28 Mn |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - | 575.47 Mn |
| 10 | CDT Equity | 1.65 Mn | 1.65 Mn | - | 631,080.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 631,080.00 |
| Mar 31, 2026 | 73,046.00 |
| Dec 31, 2025 | 3,330.00 |
| Sep 30, 2025 | 2,163.00 |
| Jun 30, 2025 | 552.00 |
| Mar 31, 2025 | 130.00 |
| Dec 31, 2024 | 29.00 |
| Sep 30, 2024 | 32.00 |
| Jun 30, 2024 | 25.00 |
| Mar 31, 2024 | 25.00 |
| Dec 31, 2023 | 25.00 |
| Sep 30, 2023 | 24.00 |
| Jun 30, 2023 | 1.00 |
| Mar 31, 2023 | 2.00 |
| Dec 31, 2022 | 4.00 |
| Sep 30, 2022 | 5.00 |
| Jun 30, 2022 | 5.00 |
| Mar 31, 2022 | 3.00 |
| Dec 31, 2021 | 1.00 |